Patient | Gender | Age (years) | Staging | Histology | Smoking history | Driver mutation | Tumor size (cm) | Tumor location | Underlying pulmonary diseases |
1 | Male | 74 | IIA | Lung adenocarcinoma | Non-smoker | 4.5 | Peripheral | ||
2 | Male | 72 | IA | Lung adenocarcinoma | Non-smoker | EGFR (p.Glu746_Ala750del) | 1.6 | Peripheral | History of community-acquired pneumonia 18 months prior to NSCLC diagnosis |
3 | Female | 71 | IA | Lung adenocarcinoma | Non-smoker | EGFR (p.Glu746_Ala750del) | 2 | Peripheral | |
4 | Female | 60 | IA | Lung adenocarcinoma | Smoker | BRAF (p.Val600Glu) | 2 | Peripheral | |
5 | Male | 69 | IA | Lung adenocarcinoma | Non-smoker | EGFR (p.Glu746_Ala750del) | 3 | Peripheral | |
6 | Male | 62 | IA | Lung squamous cell carcinoma | Smoker | 3 | Peripheral | ||
7 | Male | 50 | IA | Lung squamous cell carcinoma | Smoker | 1.2 | Peripheral | ||
8 | Female | 66 | Limited stage | Small cell lung cancer | Non-smoker | 1.5 | Peripheral | ||
9 | Male | 56 | IA | Lung adenocarcinoma | Non-smoker | EGFR (p.Glu746_Ala750del) | 1.8 | Peripheral | Pulmonary embolism |
10 | Female | 68 | IA | Lung adenocarcinoma | Smoker | KRAS (p.Gly12Cys) | 2.8 | Peripheral | COPD |
11 | Female | 78 | IA | Lung adenocarcinoma | Non-smoker | EGFR (p.Leu858Arg) | 1.6 | Peripheral | |
12 | Male | 58 | IIB | Lung squamous cell carcinoma | Smoker | 3.5 | Central | COPD |
COPD, chronic obstructive pulmonary disease; NSCLC, non-small cell lung cancer.